Company Data

Palisade Bio Inc.

Ticker
PALI
Current Price
$0.742 7.96%
Market Cap
$3.6M
Price Target
Refer to Report
Volume
65.0K
52wk Range
$0.6 - $5.15
Advanced Market Data

Overview

Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio’s innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy